Back to search

Article

The Clearance of Human Cytomegalovirus Using CRISPR/Cas9 RNA Lipid Nanoparticles

2025-12-17

Abstract excerpt

Human cytomegalovirus (HCMV), a DNA virus, poses significant health risks to immunocompromised and immunosuppressed individuals and newborns. Clinical antiviral drugs like ganciclovir inhibit viral replication but have toxicities, are ineffective against drug-resistant strains, and cannot destroy HCMV DNA. CRISPR/Cas9 can cleave DNA, but has not been used therapeutically to target and degrade HCMV DNA in cells pos...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e7f2f911-5383-5e85-84bc-c5ea2e24aa5f
DOI
10.64898/2025.12.17.694960
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Clearance of Human Cytomegalovirus Using CRISPR/Cas9 RNA Lipid NanoparticlesDOI 10.64898/2025.12.17.694960
Select a neighboring publication to make it the new centre.